Get started

Strongfundamentals

GRWRHITECH - 3 Months Downtrend Breakout Garware Hi Tech Films Ltd 1) Time Frame - Daily. 2) The Stock has been in a Downtrend since (February, 2024). Now It has given a Downtrend / Consolidation breakout & Closed with good volume & good bullish momentum candle in Daily Time Frame. 3) The next resistance would be it's Previous Life Time High (2200 - 6.25% from the price 2070.30). If the stock gives another breakout at (2200) It may move higher and find resistance around (2680 - 29.45% from the price 2070.30). 4) Stock with good fundamentals. 5) Recommendation - Strong Buy
NSE:GRWRHITECHLong
by SHRIHARII
SOUTH INDIAN BANK READY FOR BIG MOMENT#SOUTH INDIAN BANK MultiYear Breakout with big Volume on Weekly chart. Techincal RSI-Above(50) RS-Positive Fundamental Looking Good Int. On Advance-Increasing(Qtrly Basis) Total Net Profit-780 Cr(including All 3 Qtr 2023-24) Total Net Profit-775 Cr(fy-2023) Net NPA-1.61%(Declining qtry basis) Positive PE-6 Apprx(below Industry PE-17) Strategy-Buy on Dip Stop Loss-Super Trend Disclaimer-This analysis is only for learning Purpose Please do your self Study Note:- Be cautious before Interim budget
NSE:SOUTHBANKLong
by sudhanshupaliwal50
1
Buy out the dip of 1350 in InfosysNSE:INFY is one the leading IT consultancy company which does not need any description. Infy recently broke 1360 levels. Investors might add this scrip in their portfolio at current levels. Also one can average out if we see 1300 levels. No chart patterns are favourable Nothing so called trend reversal This is an effect of unfavourable market conditions The rising dollar index This might soon settle in near time and we might see 20% upside i.e 1600 levels. before the end of this year
NSE:INFYLong
by jay-chopra
3
Vinyl Chemical Breakout 1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price) 4. Sell on RSI close below 30 (or use any other method of your liking) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Weekly tailing tops with high volume c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop After a consolidation since October 2021, NSE:VINYLINDIA has given a breakout today. Buy with a stop just below ₹291. Vinyl Chemicals (India) Limited, a Parekh Group Company, is engaged in the business of trading in Chemicals mainly Vinyl Acetate Monomer (VAM), which is imported/sourced from various global suppliers and distributed in India. Strengths: - 1. TTM Sales growth is at 114% and TTM Profit growth is at 199%. 2. 10 year and 5 year average ROE more than 20%. 3. Debt to equity at 0.01 (less than 1 is good), Interest Coverage at 266 (greater than 3 is good), FCF to CFO at 100%. 4. Dividend yield at 1.55% (consistent dividend payer since 2011). 5. FIIs increased stake from 0.07 in December 2021 to 0.42 in June 2022. 7. ADX > 29 on daily chart Weaknesses: - 1. March quarter sales growth was at -27% 2. Stock is trading at 6.37 times of its book value Disclaimer: I am not SEBI Registered. Do trade or invest at your own risk, I am not responsible for any losses and won't claim anything from your profits either. Take financial advices from your advisors before jumping in.
NSE:VINYLINDIALong
by akashbothra
TATA CONSUMER PRODUCTS broke triangle patternNSE:TATACONSUM a less known company with well known products like TATA salt, TATA tea, Tetley green tea and Starbucks and much more, have finally broken out of its triangle consolidation after 6 failed attempts in the past one year. Fundamentally & financially strong with consistent group in revenue & profits, low dept to assets ratio, consistent dividend yield, reasonable PE ratio, consistent FII holding, increasing market share seems like a good scrip to have in our portfolio. Price wise current price 837.45 is just 5.8% below its all time high of 889, hence this might be a costly entry and the breakout is not with very high momentum. Also the DIIs consistently reducing their state from March 2021. However, from its pros perspective, even in short term if this scrip corrects a bit, averaging out will not be a bad option, as in long term it seems to be healthy. Entry : 820 to 840 Target : Trailing stop loss with partial profits booking method at every 5% up movement Exit : SL1 800 (resistance break), SL2 780 (support break), long term holders can average instead of exit Key note : Always follow proper risk management to avoid losing capital from false breakouts as this is common. Caution : This is a knowledge sharing analysis, not a call.
NSE:TATACONSUM
by samplespaz
ORACLE FIN SERVICE is nearing triangle breakoutNSE:OFSS is nearing triangle breakout Entry : Conservative traders, wait for breakout with volume above average and then take position. For small SL, enter on strong close above 3180 Exit : When the setup is invalidated by false breakout, or strong close below the triangle's support line Target : 4200, giving around 32% returns from current price of 3147.70. Follow trailing stoploss as IT stocks are in a continuous downtrend for long time. Midcap IT related company with strong fundamentals & financials. Income statement is good, debt to asset ratio and PE ration are very low, contributing to the pros. FII are constantly reducing their stake in this scrip from 2021 Mar, however the scrip rallied from 3000 to 5000 (66%) by the help of DII. Key note : Always follow proper risk management to avoid losing capital from false breakouts as this is common. Caution : This is a knowledge sharing analysis, not a call.
NSE:OFSS
by samplespaz
Borosil bounce back from support1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or daily RSI closing below 40 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Weekly tailing tops with high volume c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop NSE:BORORENEW is trading in a range since December 2021. On 5th April 2022 it broke out of a consolidation zone within the range, went back below the support on 12th April and gave a bounce back today. It's a buy with a stop at ₹610. Other fundamentals: 1. BRL is engaged in the manufacturing of low iron solar glass for application in photovoltaic panels. They are the first and the only producer of solar glasses in the country. The Company’s thinner fully tempered solar glass (2mm and 2.5 mm) offers niche products for glass modules. 2. BRL has a 40% market share in the Solar Glass segment. BRL has expanded its glass capacity from 180 TPD to 450 TPD, which is equivalent to the production of 2.5 gigawatts of solar modules annually. 3. During FY20, the company successfully raised 200 Cr through QIP and the money raised through the issue will be utilized for its expansion. The company will more than double its solar glass production capacity from 450 tons per day to 950 TPD. Capacity is being further expanded from 950 TPD to 1950 TPD in phases by 2024. 4. Increase in installed capacity of Renewable Energy is a high priority of government of India which continues to provide strong thrust to the installation of solar power projects. The government has announced three major steps underlining its commitment to the establishment of a strong domestic solar manufacturing eco-system. The first is the announcement of an additional allocation of Rs.19500 Crores under the PLI scheme for solar cells and modules raising the total allocation to a very impressive Rs.24000 Crores. The second is the formal announcement of basic customs duty on solar panels at 40% and on solar cells at 25% effective from 1st April 2022. The third is the scheme of Approved list of Models and Manufacturers introduced some months ago whereby effectively only Indian manufacturers of solar modules are able to supply to many types of government tenders which have now been extended to open access and net metering projects as well. (excerpt from investor call February 2022) 5. Even though 14 Gigawatts of solar module manufacturing capacity exists in India, actual production was about 5.5 Gigawatts during the financial year 2021. We see installed capacity rising to 50 Gigawatts of solar panels within the next three years. This will give a great boost to domestic production of solar equipment in India causing a major shift away from imports from China to sourcing from domestic manufacturers. Consequently, we expect increased demand for solar glass in India. We are in advanced discussion with many of these manufacturers who are all looking to have a local source of supply for solar glass. 6. The European Union has launched a solar accelerator program to promote production of solar modules in Europe. Solar components are likely to enjoy a sweet spot for the next many years. It is heartening to note that the solar installations in the country have picked up momentum in the current year. The installations in the first nine months of FY2022 have been 9.2 Gigawatts, which has matched the earlier best for a full year. This trend is expected to gain further ground and the level of annual installations is expected to accelerate to significantly higher levels. There is a growing demand from export customers looking at the expected significant rise in local production of solar modules in major markets i.e. to say Europe and USA. We see an attractive future growth in the company’s exports. 7. Borosil Renewables is currently undertaking a Brownfield capacity expansion, a third solar line with a capacity of 550 metric tons to meet the growing demand. This will enhance our capacity from 450 tons per day to 1000 tons per day. Commercial production from SG-3 is expected to commence in the second quarter of FY2023. Further, the company’s board has already approved further expansion of capacity through Solar Glass 4 & 5 in order to raise the capacity from 1000 tons to 2000 tons per day. Work on the SG-4 project is expected to commence during the second quarter of CY2022. Given the lead times required for capacity expansion this additional capacity can come on stream in the third quarter of CY2023. 8. The company has delivered good profit growth of 25.44% CAGR over the last 5 years. 9. Quarter sales growth at 20%, quarter profit growth at 332%, TTM sales growth 64% and TTM profit growth at 595% (December quarter). 10. Debt to equity at 0.10 (less than 1 is good), Interest Coverage at 62.5 (greater than 3 is good), Current ratio at 5.60 (greater than 1.5 is good). 11. Borrowings came down from 92Cr. in Mar'20 to 71Cr. in Sep'21.
NSE:BORORENEWLong
by akashbothra
Ruchira papers break out1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula: - Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a quarterly sales and profit growth of 27% and 1365% respectively and TTM sales growth of 48% and TTM profit growth of 730%, NSE:RUCHIRA gave a high volume break out today from an 8-month long consolidation zone. Buy with a stop around rupees 92. Other fundamental: 1. According to stock market experts, paper mills are least affected by recent global triggers like Ukraine-Russia war, soaring crude oil price and other commodity prices ascending to its multi-month highs. In fact, unlock theme has fueled demand for papers as schools and other educational institutions are reopening now. Recently pulp and waste paper prices in the international markets have gone up that may give margin benefits to the paper mills in upcoming quarters. 2. The Company has a manufacturing unit in Sirmaur, Himachal Pradesh. The current installed capacity stands at 400 TPD. This includes 250 tonnes per day of Kraft Paper and 150 tonnes per day of writing and printing paper. It also has a 8.1 MW captive power plant at its Kala Amb facility which helps source 100% of the power requirement of writing & printing paper from within. 3. The Co launched white copier paper and bleached kraft, which is used for the manufacture of carry bags with quality equivalent to the imported grade of bleached kraft in the market. The newly launched product constituted 12% of the revenues from writing and printing papers in FY21. 4. The Co is focusing on repayment of its long-term borrowings in FY22 and derisking of the balance sheet. 5. Stock is trading at 0.98 times its book value. 6. Promoter holding has increased by 1.36% over last quarter. 7. Debt to equity at 0.22 (less than 1 is good), Interest Coverage at 6.84 (greater than 3 is good), Current ratio at 1. 63% (greater than 1.5 is good). 8. Sector leader in terms of one month and six months' return.
NSE:RUCHIRALong
by akashbothra
Suven Pharma high volume breakout1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a consolidation since August 2021 NSE:SUVENPHAR gave a high volume break out today. It is a buy with a stop around Rs. 544. Other fundamentals: 1. SPL engages in NCE molecule development and supply of intermediates. This is a high-value-add, high-margin business. SPL supplies intermediates for four molecules addressing rheumatoid arthritis, diabetes, depression and women’s health. This segment makes up 78% of revenues. The company has a strong order book with new clients being consistently added. Most clients are the Big Pharma companies in Europe and the US. The company is looking to shift from Intermediate to API manufacturing and is in discussion with clients regarding this. The company has stated that it has the facilities for API manufacturing. 2. The Company is supplying intermediates – derived out of its CDMO competence – for two specialty chemical products (agrochemical) to large global conglomerates. In this segment, the company is currently working on two molecules with a new molecule to be developed next year. 3. The company has planned for a capex of Rs 600cr, a large part of which will be utilized in facility upgradation, technology enhancement and relocation spread over 3 years. This will be over and above the current ongoing capex of Rs 320cr spent over FY19-21. The capex would be mainly used for modernization of manufacturing facilities, relocation of R&D facilities and acquisition of new technologies. The company has already spent a Capex of Rs.94cr in 9MFY21 to expand its existing manufacturing facilities. 4. Suven Pharma is associated with more than 70 global companies. The company has an established market position in the CRAMS segment and is among the top five players in India who supply high-end intermediaries to innovators. Company is getting repeat business owing to long standing relationships with MNC companies. The industry has high entry barriers, needs deep technical expertise and is a sticky business. 5. Suven Pharma Inc. is a wholly owned subsidiary of SPL. It is a Special Purpose Vehicle created to invest in Rising Pharma Holdings Inc. Suven Pharma Inc. has 25 % holding in Rising Pharma Holdings Inc. Rising Pharma Holdings Inc. is a New Jersey, USA based pharmaceutical company focused on developing generic pharmaceuticals products in various therapeutic segments. 6. Company has reduced debt. 7. Debtor days have improved from 76.94 to 37.01 days. 8. Since June 2020 FII steak increased from 3.55 to 8.25. 9. Debt to equity at 0.10 (less than 1 is good), Interest Coverage at 104 (greater than 3 is good), Current ratio at 3.19 (greater than 1.5 is good).
NSE:SUVENPHARLong
by akashbothra
TTK Healthcare break out 1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a quarter sales growth of 18%, quarter profit growth of 58%, TTM sales growth of 30% and TTM profit growth off 39%, NSE:TTKHLTCARE has given a high-volume breakout today after a consolidation since July 2021. One can buy with a stop at Rs. 798. Other fundamentals: - 1. TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India. 2. The company's pharmaceuticals business include products for both human and veterinary use :- a. Ethical Products/ Pharma Division - The company's ethical pharma business deals in pharmaceutical formulations both herbal and allopathic, in various therapeutic segments and food supplements. It has a network of 1000+ sales team and a network of 3000+ distributors. b. Animal Welfare Division - The company sells a wide range of animal pharma products under this division. Its portfolio includes feed supplements, fertility inducers, antibiotics, cocktail enzymes, etc. Its network is spread over 9,000 veterinarians across India. 3. The company's consumer products business comprises of marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good home range of scrubbers, air freshners, etc. The company's brand 'Woodward's Gripe Water' is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. Its distribution network includes 27 warehouses, 2,600+ distributors, 650+ frontline sales team and a reach to 4 lakh+ outlets across India. 4. The company is one of the largest manufacturers of extruded products (papad) in India which are B2B and export customers and are also marketed in selected markets in India. It sells its products under the brand name 'Fryums'. 5. Company is one of the key players in the Indian Condom Industry. It is involved in manufacture and marketing of male contraceptives and other allied products. It sells products under its own brand 'SKORE'. 6. The company's medical devices business is divided into 2 divisions :- a. Orthopedics Division- The company's orthopedics division offers joint replacement portfolio which includes a variety of components, types and sizes. It has technical collaborations with various companies situated in USA, Germany, UK & Italy for the orthopedics business. b. Heart Valve Division - The division manufactures and distributes heart valve prosthesis in India. It manufactures all 3 components for heart valve i.e. Frame, Disc & sewing ring. It has a manufacturing capacity of 20,000 heart valves p.a. 7. Presently, the company owns and operates 8 manufacturing facilities in India in Karnataka, Tamil Nadu, Puducherry, Kerala, and Rajasthan. It has adopted an outsourcing model for manufacturing most of its products, except for foods, medical and protective devices divisions. 8. Promoter Holding at 75% (greater than 45% is good) 9. Dividend Yield at 0.67% (consistent dividend payer since 2010) 10. Debt to equity at 0.02 (less than 1 is good), Interest Coverage at 17.3 (greater than 3 is good), Current ratio at 1.99% (greater than 1.5 is good), FCF to CFO at 59% (company won’t have to raise debt for expansion)
NSE:TTKHLTCARELong
by akashbothra
Jasch is keeping the fight aliveWith quarterly sales increasing by 42% and quarterly profit increasing by 68%, BSE:JASCH posted good set of numbers. This share gave breakout on 2nd Feb and was a buy with a stop at or below Rs.150. Within these volatile markets this share is coming back to it's buy zone again and again and trying to move up. It's still a buy with the same stop loss. Other Fundamentals: - 1. Average ROE for last 5 years above 15% 2. TTM sales growth at 72% and TTM profit growth at 136% 3. Borrowings came down from Rs .23cr to Rs .3cr since Mar'19 4. Debt to equity at 0.04, Interest coverage ratio at 47.9 and ROCE at 24% 5. During FY21, the Co was able to improve the drying speed of PVC coated fabrics in its existing ovens, as a result of which the installed capacity of PVC coated fabrics being manufactured has increased from 78 lakh metres to 94 lakh metres p.a. 6. Some of the major clients of the co include Puma, Red Tape, Bata, Mahindra, Walmart, Calvin Klein etc. 7. The company has recently modified its production lines, which has resulted in development of some new products with significant saving in power and fuel. The company has been concentrating on PU resin and PU Synthetic Leather where the competition is less.
JLong
by akashbothra
HINDUNILVR: At strong support and MA SupportSo the idea is, you can clearly see HINDUNILVR is at strong support zone of 2304 and also touching at 20 period MA and as per history trend whenever HINDUNILVR touches 20 MA it bounces back. HINDUNILVR respect 20 MA a lot (I have marked the instances on chart) but thing is previous instances were monthly candles but today its almost start of month so I think this time it will break 20 MA support and can reach to 2229 area then bounce back from bottom. Not giving Targets or SL for HINDUNILVR as this stock is just to buy whenever you got chance to get it. HINDUNILVR has Strong Fundamentals. Note: I'm new to technical analysis , do your own maths. I'm open to new ideas and flaws in my analysis, so please do comment and collaborate. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial adviser before taking any trade.
NSE:HINDUNILVR
by hrprtsnghsht